Table 10_1_18.1
Adverse events in patients receiving hip joint replacement due to degenerative conditions, United States, 2004 and 2006a
Population group |
2006 |
2004 |
Exposed |
Adverse events |
Percent |
SE |
Exposed |
Adverse events |
Percent |
SE |
Total |
* |
* |
* |
* |
306 |
15 |
4.90 |
1.23 |
Age |
Under 65 |
* |
* |
* |
* |
* |
* |
* |
* |
65–74 |
* |
* |
* |
* |
* |
* |
* |
* |
75 and over |
* |
* |
* |
* |
157 |
14 |
8.92 |
2.27 |
Gender |
Male |
* |
* |
* |
* |
* |
* |
* |
* |
Female |
* |
* |
* |
* |
* |
* |
* |
* |
Race |
White |
* |
* |
* |
* |
286 |
15 |
5.24 |
1.32 |
Other |
* |
* |
* |
* |
* |
* |
* |
* |
Diabetes |
Yes |
* |
* |
* |
* |
* |
* |
* |
* |
No |
* |
* |
* |
* |
261 |
12 |
4.60 |
1.30 |
Obesity |
Yes |
* |
* |
* |
* |
* |
* |
* |
* |
No |
* |
* |
* |
* |
275 |
14 |
5.09 |
1.33 |
Cerebrovascular disease |
Yes |
* |
* |
* |
* |
* |
* |
* |
* |
No |
* |
* |
* |
* |
276 |
14 |
5.07 |
1.32 |
CHF/pulmonary edema |
Yes |
* |
* |
* |
* |
* |
* |
* |
* |
No |
* |
* |
* |
* |
283 |
14 |
4.95 |
1.29 |
COPD |
Yes |
* |
* |
* |
* |
* |
* |
* |
* |
No |
* |
* |
* |
* |
* |
* |
* |
* |
Smoking |
Yes |
* |
* |
* |
* |
* |
* |
* |
* |
No |
* |
* |
* |
* |
280 |
13 |
4.64 |
1.26 |
Cancer |
No |
DNA |
DNA |
DNA |
DNA |
253 |
12 |
4.74 |
1.34 |
Yes |
DNA |
DNA |
DNA |
DNA |
* |
* |
* |
* |
Corticosteroids |
Yes |
* |
* |
* |
* |
* |
* |
* |
* |
No |
* |
* |
* |
* |
296 |
14 |
4.73 |
1.23 |
Coronary artery disease |
Yes |
* |
* |
* |
* |
* |
* |
* |
* |
No |
* |
* |
* |
* |
239 |
11 |
4.60 |
1.36 |
Renal disease |
Yes |
* |
* |
* |
* |
* |
* |
* |
* |
No |
* |
* |
* |
* |
292 |
13 |
4.45 |
1.21 |
a Data include Medicare beneficiaries discharged from January to December.
DNA - Data have not been analyzed.
* - Data do not meet the criteria for statistical reliability, data quality, or confidentiality.
Key: CHF: congestive heart failure; COPD: chronic obstructive pulmonary disease; SE: standard error.
Source: Centers for Medicare & Medicaid Services, Medicare Patient Safety Monitoring System.